A Practical Approach To Diagnose and Treat Rickets: Journal of Clinical Medicine of Kazakhstan (E-ISSN 2313-1519)
A Practical Approach To Diagnose and Treat Rickets: Journal of Clinical Medicine of Kazakhstan (E-ISSN 2313-1519)
A Practical Approach To Diagnose and Treat Rickets: Journal of Clinical Medicine of Kazakhstan (E-ISSN 2313-1519)
Abstract
Rickets is a disease of growing bone, before fusion of epiphyses.
There is defective mineralization of cartilage matrix in the zone
of provisional calcification caused either by nutritional vitamin D
deficiency and/or low calcium intake or by non-nutritional causes, like
hypophosphatemic rickets and rickets due to renal tubular acidosis.
In addition, some varieties are due to inherited defects in vitamin D
metabolism and are called vitamin D dependent rickets. The diagnosis
Received: 2020-12-05. is made on the basis of history, physical examination, and biochemical
Accepted: 2020-12-27 testing, and is confirmed by radiographs. Treatment consists of vitamin
D supplementation as Stoss therapy or daily or weekly oral regimens,
all with equal efficacy and safety, combined with calcium supplements.
For renal rickets, the active form of Vit D, 1,25(OH)2 also called Calcitriol is
used, treatment is tailored to another type of renal rickets.
Routine supplementation starting from the newborn period is being
J Clin Med Kaz 2021; 18(1):7-13
increasingly endorsed by various international organizations. Adequate
sunlight exposure, food fortification, and routine supplementation are
the currently available options for tackling this nutritional deficiency.
Corresponding author: In this review article, we discuss the pathophysiology, diagnosis, and
Ashish Jaiman. management of rickets in detail.
E-mail: drashishjaiman@gmail.com; Key words: rickets, vitamin D, hypophosphatemic rickets, renal
rickets
Diagnosis
Diagnosis is based on clinical features along with
radiological changes and distinct biochemical changes.
Clinical Findings: Generally these children have failure
to thrive, lethargy, protruding abdomen, proximal muscle
weakness, dilated cardiomyopathy and high risk of bony
fractures. Specific clinical findings are:
Head: Craniotabes, frontal bossing, delayed closure of
fontanel, craniosynostosis with or without signs of increased
intracranial pressure, delayed dentition (suggestive if there is
no eruption of incisors by age 10 months or molars by age 18
months) and dental caries.
Chest: Physical findings include rachitic rosary and
Deformities and pathological features can occur in
Harrison groove. Frequent respiratory infections are common
advanced forms of rickets (Figure 2) [13]. Sabre Tibia that has
and one may find atelectasis on the chest-x-ray.
a pronounced anterior convexity resembling the curve of a sabre
Back: Scoliosis, kyphosis and lordosis may be evident
is classically described for syphilis may also be present in rickets
Appendicular skeleton: bilateral enlargement of wrist
that gets healed after vitamin D correction (Figure 3a-b).
and ankles, valgus or varus deformities of the knee, windswept
Biochemical findings:
deformity (valgus deformity of one leg with varus deformity of
a) Serum ALP values: It is a marker of disease activity
other leg), anterior bowing of tibia and femur, coxa vara and leg
because it partakes in the mineralization of bone and growth
pains.
plate cartilage. Both hypocalcemic and hypophosphatemic
Hypocalcemic symptoms: Children may present with
rickets have raised serum ALP levels [21].
Journal of Clinical Medicine of Kazakhstan: 2021 Volume 18, Issue 1
9
Figure 3a - AP X-ray of 4 year old child showing curved tibia – Figure 3b - AP X-ray of same child after 6 months of treatment
Sabre tibia- with signs of rickets showing resolution of rickets with correcting deformity
b) Serum calcium values: It is usually low in calcipenic body and thus, is low in vitamin D deficiency, while it is normal
rickets, but may be normal in initial stages of the disease due to or slightly increased in the other forms.
increase in PTH levels [11]. It is normal in phosphopenic rickets. f) Serum 1, 25(OH) 2 vitamin D values: It is the activated
c) Serum phosphorus values: Its values are usually are low form of vit D and it can be low, normal, or increased in calcipenic
in both calcipenic and phosphopenic rickets. rickets. 1, 25(OH) 2 vit D levels initially increase in response to
d) Serum PTH values: It is elevated in calcipenic rickets rising levels of PTH, but may afterwards decrease because its
and usually normal in phosphopenic rickets. base material 25(OH) D is limited. 1, 25(OH) 2 vit D is increased
The diagnostic flowchart of suspected rickets use values in VDDR type II and hypophosphatemic rickets.
of serum inorganic phosphorus (iP) and PTH to distinguish g) For children with phosphopenic rickets, the causes can
calcipenic from phosphopenic rickets [22]. be distinguished by measuring urinary amino acids, bicarbonate,
e) Serum 25(OH) D values: It helps to distinguish rickets glucose, and calcium concentrations. A summary of biochemical
caused by vitamin D deficiency from other causes of calcipenic changes seen in different types of rickets is discussed in Table 2.
rickets [11]. It reflects the amount of vitamin D stored in the
VDDR I Low Low High High High 25(OH)D low Low Normal
1,25 (OH)D
VDDR II Low Low High High High 25(OH)D and Normal
1,25(OH)D both
Hypophosphatemic Normal Low High Normal Normal 25(OH)D High Normal
Low 1,25 (OH)D
Renal failure Low High High High Low 25(OH)D and Low
1,25(OH)D
Levels of 25(OH) D are assessed for the purpose of chemiluminescence or radioimmuno assay are commonly used
defining deficiency [23]. Various methods can be used, the methods. Although a fasting specimen is recommended, it is not
best being TMS (Tandem Mass Spectrometer), but is not essential; diurnal variations are also not so important [24, 25].
performed routinely. Enzyme-linked immunosorbent assay, Data suggest that 20 ng/mL (50 nmol/L) can be set as the serum
Treatment
Depending on cause of rickets, the treatment varies, in
terms of which form of vitamin D is used for supplementation
along with dosing of calcium and phosphorous.
For nutritional rickets: Contrary to the popular conception;
oral administration of vitamin D replenishes vitamin D
concentrations more quickly than by the intramuscular (IM)
route [26, 27]. When absorption from the gut or compliance is an
issue; intramuscular route is prescribed. Moreover, absorption is
independent of fed state [23, 27].
For neonates and infants till 1 year of age, daily 2000 IU
of vitamin D with 500 mg of calcium for a 3-month period is Figure 4b
mentioned. At the end of 3 months, response to treatment should
be reevaluated and treatment continued [26, 27]. If larger doses
of vitamin D are to be given, then, 60,000 IU of vitamin D
weekly for 6 weeks is recommended (only in infants older than
3 months of age). After completion of this therapy with weekly
doses, maintenance doses of 400 IU of vitamin D daily and 250-
500 mg of calcium are required [27].
From one year onwards till 18 years of age, 3000-6000 IU/
day of vitamin D along with calcium intake of 600-800 mg/day
is recommended for a minimum of 3 months. For larger doses,
60,000 IU of vitamin D weekly for 6 weeks may be given orally
[27, 28]. The maintenance doses of 600 IU/day of vitamin D and
600-800 mg of calcium need to be continued after therapy [27].
An alternative protocol is “Stoss therapy,” which consists
of a high dose of oral vitamin D (600,000 IU) given on a single
day, (age more than 12 months), or 300,000 IU (age less than 12
Figure 4c - AP X-ray of same child at 3 months post Stoss
months) then maintained at 400–1000 IU of vitamin D per day therapy showing resolution of rickets
for 8 weeks orally followed by 400 IU/day [11]. The X-ray at
3 weeks in patients responding to therapy shows characteristic
white line of healing with complete resolution by 3 months
(Figure 4a-c) [1]. Stoss therapy is useful when compliance is
a problem. However, Stoss therapy (from the German “push”)
can result in hypercalcemia and nephrocalcinosis [28]. Doses of
150,000 or 300,000 IU are also similarly effective with lesser
side effects [11].
Vitamin D dependent rickets (VDDR) Type 2 (Also known
as hereditary resistance to vitamin D – HRVD): Treatment
contains unusually high doses of calcitriol and calcium for 3-5
months. Initial dose of 1,25 D is 6 mcg/day along with calcium
supplementation. It is gradually increased to very high doses up
to 60 mcg/ day and calcium up to 3 gram per day with the aim
to achieve normal calcium levels and X ray evidence of healing
[13]. hypercalciuria and hypocitraturia being used for dose titration.
Rickets due to renal osteodystrophy: Treatment includes Symptomatic treatment including replacement of fluids,
vitamin D in the form of cholecalciferol, phosphate restriction bicarbonates and potassium, supplement oral phosphates along
in diet and use of phosphate binders. Calcium based phosphate with vitamin D as 1,25(OH)2 vitamin D, forms the principles of
binders are safe and effective such as calcium carbonate, treatment [11, 13].
calcium acetate and calcium gluconate. In the presence of high Renal rickets with hypocalcemia (Secondary
serum calcium levels, calcium containing phosphate binders hyperparathyroidism) Vitamin D-dependent rickets type 1
may cause soft tissue calcification. Newer non-calcium-non- (VDDR 1): Treatment is with 1, 25(OH) 2 vitamin D, 0.25-2.0
aluminum phosphate binding drugs like Sevelamer are used in mcg per day. This is continued till X ray evidence of healing is
these situations [13]. seen. After this, maintenance dose is given as 0.25-1.0 mcg /day
Renal rickets with Type I (distal) renal tubular acidosis depending on the severity and body weight. This is combined
(dRTA) and without renal failure: Patients with dRTA demands with elemental calcium supplementation of 30-75 mg/kg/day.
an alkaline dose of 1-3 mEq/kg/day, with normalization of During therapy serum calcium is kept at lower limit of normal,
normal phosphate and high normal levels of PTH [17, 19].
Journal of Clinical Medicine of Kazakhstan: 2021 Volume 18, Issue 1
11
Hypophosphatemic rickets: In rickets due to FGF23, Pregnant mothers and lactating females should receive 600
treatment consists of oral administration of phosphate and 1, 25 IU of vitamin D daily [26, 30] along with 1200 mg of calcium
(OH) 2 vitamin D. The recommended oral phosphate preparation [31].
consists of the solution of 136 g of dibasic sodium phosphate and Children older than 1 year and adolescents: 600 IU of
58.5 g phosphoric acid (85%) in a liter of water. One milliliter vitamin D [26, 27] and 600-800 mg/day calcium [31].
of solution contains 30 mg of elemental phosphorus. Prepared At-risk groups: Children on anti-seizure medications,
oral formulations are available for ready use. The recommended children on treatment for malignancy, restricted sun exposure
dose of phosphate varies from 30-90 mg/kg/day, with an average such as in children with physical disabilities, children with fat
of 60 mg/kg/day divided into four doses [13]. Treatment with malabsorption, liver disease or renal insufficiency, transplant
phosphate solution be administered simultaneously with low recipients, those with history of rickets, children with
doses of active vitamin D and one shall gradually increase the predisposition to osteoporosis such as in hypogonadism or
dose. The recommended dose is between 0.02-0.03 μg/ kg/ Cushing’s syndrome, etc., requires higher doses of vitamin D
day [16]. Nephrocalcinosis and hyperparathyroidism must be [23, 26, 27].
monitored during the course of therapy. Adjuvant therapy with Thus, for at-risk infants, 400-1000 IU/day and from 1 year
hydrochlorothiazide is used by some to control hypercalciuria onwards, 600-1000 IU/day along with adequate calcium intake
[13]. as per the age group is recommended [27, 32].
Whilst in renal tubule defect, as in HHRH (Hereditary
hypophosphatemia rickets with hypercalciuria), treatment Conclusion
is phosphate supplementation alone whereas the addition of Nutritional Rickets and osteomalacia are avertable
vitamin D can create complications, such as hypercalcemia, diseases that are on the rise in undeveloped world particularly.
nephrocalcinosis and renal damage [13]. In Dents disease Screening for vitamin D deficiency is suggested in individuals at
treatment of hypercalciuria is done with dietary sodium risk. Appropriate treatment corrects the upset bone metabolism
restriction and thiazide diuretics. Dietary calcium restriction and deformities. Renal causes for rickets should be considered
has been shown to worsen the risk of bone disease. Oral if there is no or little response to vitamin D supplementation and
phosphate therapy and active vitamin D supplementation result other associated features. A normal serum creatinine dismisses
in improvement of bone disease. Dialysis and transplantation are renal osteodystrophy. The presence of acidosis points towards
the terminal treatment offered to these patients if they develop RTA. Further differentiation between types 1 and type 2 RTA is
stage V CKD [13]. possible by estimating urine pH. The absence of acidosis indicates
either hypophosphatemic rickets or VDDR. Hypophosphatemic
Prevention rickets shows renal phosphate wasting, while VDDR can be
Preventive measures in high risk groups as discussed identified by measuring serum vitamin D. Overall, the treatment
below will lessen the burden of rickets and need for treatment. depends on etiology, hence a detailed systematic assessment is
Premature neonates: Enteral calcium intake of about 150 essential
to 220 mg/kg per day, phosphorous intake of 75-140 mg/kg/day
and vitamin D intake of 400 IU/day is suggested [27, 29]. Disclosures: There is no conflict of interest for all authors.
Neonates and infants up to 1 year of age: 400 IU of vitamin
D supplementation is recommended till one year of age. In the
first year of life, if dietary calcium intake is not adequate (250-
500 mg), calcium supplementation is recommended [27].
References
1. Greenbaum LA. Rickets and Hypervitaminosis D. In Robert Kliegman: Editor, Nelsons Textbook of Pediatrics. 1st South Asia edition.
Elsevier India. 2016; 331-341.
2. Ladhani S, Srinivasan L, Buchanan C, Allgrove J. Presentation of vitamin D deficiency. Arch Dis Child. 2004; 89(8):781-4. doi: 10.1136/
adc.2003.031385. PMID: 15269083; PMCID: PMC1720051.
3. Najada AS, Habashneh MS, Khader M. The frequency of nutritional rickets among hospitalized infants and its relation to respiratory
diseases. J Trop Pediatr. 2004; 50(6):364-8. doi: 10.1093/tropej/50.6.364. PMID: 15537725.
4. Wagner CL, Greer FR; American Academy of Pediatrics Section on Breastfeeding; American Academy of Pediatrics Committee on
Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008; 122(5):1142-52. doi:
10.1542/peds.2008-1862. Erratum in: Pediatrics. 2009; 123(1):197. PMID: 18977996.
5. Webb AR. Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol. 2006; 92(1):17-25. doi:
10.1016/j.pbiomolbio.2006.02.004. PMID: 16766240.
6. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. doi: 10.1056/NEJMra070553. PMID: 17634462.
7. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M; Drug and Therapeutics Committee of the Lawson Wilkins Pediatric
Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics.
2008; 122(2):398-417. doi: 10.1542/peds.2007-1894. PMID: 18676559.
8. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004;
79(3):362-71. doi: 10.1093/ajcn/79.3.362. Erratum in: Am J Clin Nutr. 2004; 79(5):890. PMID: 14985208.
9. Nield LS, Mahajan P, Joshi A, Kamat D. Rickets: not a disease of the past. Am Fam Physician. 2006; 74(4):619-26. PMID: 16939184.
10. Drezner MK. Rickets and osteomalacia. In: Goldman L, Ausiello DA, eds. Cecil Textbook of Medicine. 22nd ed. Philadelphia, Pa.:
Saunders, 2004:1545.
11. Sahay M, Sahay R. Rickets-vitamin D deficiency and dependency. Indian J Endocrinol Metab. 2012; 16(2):164-76. doi: 10.4103/2230-
8210.93732. PMID: 22470851; PMCID: PMC3313732.